16:26 EST Castle Biosciences sees FY24 revenue $235M-$240M, consensus $214.7M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CSTL:
- Castle Biosciences Shapes Dialogue with Strategic Presentations
- Castle Biosciences (CSTL) Q4 Earnings Cheat Sheet
- Castle study shows DecisionDx -SCC test to guide radiation in cSCC reduces cost
- Castle presents data supporting utility of tests in care of skin cancer patients
- Castle Biosciences reports preliminary FY23 revenue $210M, consensus $203.95M
